Exact Sciences
EXAS
#1945
Rank
S$10.87 B
Marketcap
$58.56
Share price
-2.89%
Change (1 day)
-35.07%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -S$1.38 Billion

According to Exact Sciences's latest financial reports the company's current earnings are S$2.75 Billion. a decrease over its 2023 earnings that were of -S$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -S$1.37 Billion435.08%
2023 -S$0.26 Billion-69.28%
2022 -S$0.83 Billion-25.55%
2021 -S$1.12 Billion1.68%
2020 -S$1.1 Billion271.17%
2019 -S$0.3 Billion58.99%
2018 -S$0.19 Billion20.89%
2017 -S$0.16 Billion-30.95%
2016 -S$0.23 Billion5.09%
2015 -S$0.22 Billion57.24%
2014 -S$0.14 Billion116.53%
2013 -S$62.06 Million
2011 -S$38.64 Million143.73%
2010 -S$15.86 Million27.85%
2009 -S$12.4 Million0.27%
2008 -S$12.37 Million-20.95%
2007 -S$15.65 Million-13.53%
2006 -S$18.1 Million-10.07%
2005 -S$20.12 Million-21.81%
2004 -S$25.74 Million-33.44%
2003 -S$38.66 Million-6.51%
2002 -S$41.35 Million17.95%
2001 -S$35.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.17 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$88.31 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$34.51 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$46.88 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.64 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France